Home › Funds › Sofinnova Investments, Inc. › IDYA
Sofinnova Investments, Inc. position in IDYA
IDEAYA BIOSCIENCES INC · Health Care
Sofinnova Investments, Inc. reported holding 946,340 shares of IDYA (IDEAYA BIOSCIENCES INC) in its Q3 2026 13F filing — a position valued at US$36.4M, representing 1.64% of its reported portfolio and ranking #16 among its reported holdings. Sofinnova Investments, Inc. has disclosed IDYA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Sofinnova Investments, Inc.'s IDYA position evolved
Sofinnova Investments, Inc. first disclosed a stake in IDYA in Q3 2023 at 1,037,187 shares (US$28.0M). The position peaked in Q3 2024 at 1,749,455 shares, worth US$55.4M. Across 13 filings, Sofinnova Investments, Inc. increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 946,340 shares valued at US$36.4M — an increase of 21,221 shares quarter over quarter.. Notable position changes include a 52% increase in Q3 2024 (shares fell 19% over the following quarter), a 145% increase in Q1 2025 (shares rose 28% over the following quarter), a 57% trim in Q3 2025 (shares rose 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.04M | $27.98M | New |
| Q4 2023 | 1.46M | $51.91M | Add |
| Q1 2024 | 781.60K | $34.30M | Reduce |
| Q2 2024 | 1.15M | $40.43M | Add |
| Q3 2024 | 1.75M | $55.42M | Add |
| Q4 2024 | 1.07M | $27.48M | Reduce |
| Q1 2025 | 2.62M | $42.95M | Add |
| Q2 2025 | 2.15M | $45.15M | Reduce |
| Q3 2025 | 922.70K | $25.11M | Reduce |
| Q4 2025 | 885.12K | $30.60M | Reduce |
| Q1 2026 | 1.13M | $37.71M | Add |
| Q2 2026 | 925.12K | $34.48M | Reduce |
| Q3 2026 | 946.34K | $36.36M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IDYA and 13F data
IDYA (IDEAYA BIOSCIENCES INC) is a Health Care company. 32 other funds we track also report a position in IDYA — the largest reported positions include BAKER BROS. ADVISORS LP (US$186.7M), Logos Global Management LP (US$109.5M), DEERFIELD MANAGEMENT COMPANY, L.P. (US$101.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IDYA
- BAKER BROS. ADVISORS LP 5.01M sh · $186.72M · Q2 2026
- Logos Global Management LP 2.85M sh · $109.50M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 2.71M sh · $101.17M · Q2 2026
- GSK plc 1.33M sh · $51.23M · Q3 2026
More on Sofinnova Investments, Inc.
FAQ
How long has Sofinnova Investments, Inc. held IDYA?
Sofinnova Investments, Inc. has disclosed IDYA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sofinnova Investments, Inc.'s current position in IDYA?
As of Q3 2026, Sofinnova Investments, Inc. holds 946.34K shares of IDYA (IDEAYA BIOSCIENCES INC), valued at $36.36M, representing 1.64% of its reported portfolio and ranking #16.
Has Sofinnova Investments, Inc. been buying or selling IDYA?
In the latest 13F filing (Q3 2026), Sofinnova Investments, Inc. increased its position in IDYA. The position peaked in Q3 2024 at 1.75M shares.
Which other funds hold IDYA?
Other major institutional holders of IDYA include BAKER BROS. ADVISORS LP, Logos Global Management LP, DEERFIELD MANAGEMENT COMPANY, L.P., among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.